Roivant Sciences Ltd. (ROIV)

Roivant Sciences Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	1,248	1,419	2,715	6,495	1,677	2,060
Short-Term Investments	2,594	2,873	2,171	-	-	-
Cash & Short-Term Investments	3,842	4,292	4,887	6,495	1,677	2,060
Cash Growth	-14.68%	-12.18%	-24.76%	287.34%	-18.62%	0.26%
Accounts Receivable	-	-	-	-	30.38	3.88
Other Receivables	21.6	-	-	-	7.27	2.85
Receivables	21.6	-	-	-	37.64	6.73
Inventory	-	-	-	-	2.76	-
Prepaid Expenses	-	-	-	-	60.83	53.37
Restricted Cash	4.2	3.86	2.36	3.07	5.01	3.9
Other Current Assets	874.2	871.69	110.82	233.81	15.53	22.12
Total Current Assets	4,742	5,167	5,000	6,732	1,799	2,147
Property, Plant & Equipment	90.21	92.4	101.08	59.32	92.34	86.95
Long-Term Investments	444.62	407.99	302.94	247.75	304.32	325.83
Other Intangible Assets	-	-	-	-	144.88	-
Other Long-Term Assets	29.59	40.92	32.86	183.58	49.48	25.82
Total Assets	5,306	5,709	5,437	7,222	2,390	2,585

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	25.08	18	23.69	14.03	37.83	34.58
Accrued Expenses	168.74	205.82	114.29	119.42	167.13	127.53
Current Portion of Long-Term Debt	-	-	-	-	40.72	-
Current Portion of Leases	12.38	11.15	9.84	8.97	11.69	11.4
Current Income Taxes Payable	74.18	45.69	0.42	9.77	0.54	0.71
Current Unearned Revenue	-	-	-	4.17	12.44	10.15
Other Current Liabilities	3.21	0.58	1.17	110.41	2.09	-
Total Current Liabilities	283.6	281.24	149.41	266.76	272.45	184.37
Long-Term Debt	-	-	-	-	375.52	210.03
Long-Term Leases	94.77	96.29	90.33	45.02	53.48	62.47
Other Long-Term Liabilities	6.25	38.74	10	462.18	80.58	66.84
Total Liabilities	384.62	416.28	249.74	773.95	782.02	523.7

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Additional Paid-In Capital	5,131	5,025	4,562	5,396	4,933	4,422
Retained Earnings	-900.35	-501.81	116.06	576.17	-3,773	-2,764
Comprehensive Income & Other	0.7	4.36	9.44	-4.08	-2.62	-0.95
Total Common Equity	4,231	4,527	4,688	5,969	1,158	1,657
Minority Interest	690.6	765.04	499.59	479.95	449.82	404.49
Shareholders' Equity	4,922	5,292	5,187	6,449	1,608	2,061
Total Liabilities & Equity	5,306	5,709	5,437	7,222	2,390	2,585

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	107.15	107.44	100.17	53.99	481.4	283.89
Net Cash (Debt)	3,735	4,184	4,787	6,441	1,195	1,777
Net Cash Growth	-15.18%	-12.58%	-25.68%	438.81%	-32.71%	-1.85%
Net Cash Per Share	5.31	6.03	6.60	7.75	1.68	2.65
Filing Date Shares Outstanding	722.32	719.27	679.81	738.72	766.81	700.77
Total Common Shares Outstanding	722.67	720.35	695.94	806.68	760.14	694.98
Working Capital	4,458	4,886	4,851	6,465	1,526	1,962
Book Value Per Share	5.86	6.28	6.74	7.40	1.52	2.38
Tangible Book Value	4,231	4,527	4,688	5,969	1,013	1,657
Tangible Book Value Per Share	5.86	6.28	6.74	7.40	1.33	2.38

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 28, 2026

Data Sources Report a data error